ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
2024 Kiladjian, Jean-Jacques; Marin, Francisca Ferrer; Al-Ali, Haifa Kathrin; Alvarez-Larrán, Alberto; Beggiato, Eloise; Bieniaszewska, Maria; Breccia, Massimo; Buxhofer-Ausch, Veronika; Cerna, Olga; Crisan, Ana-Manuela; Danaila, Catalin Doru; De Stefano, Valerio; Döhner, Konstanze; Empson, Victoria; Gora-Tybor, Joanna; Griesshammer, Martin; Grosicki, Sebastian; Guglielmelli, Paola; García-Gutierrez, Valentin; Heidel, Florian H.; Illés, Arpád; Tomuleasa, Ciprian; James, Chloe; Koschmieder, Steffen; Krauth, Maria-Theresa; Krejcy, Kurt; Lazaroiu, Mihaela-Cornelia; Mayer, Jiri; Nagy, Zsolt György; Nicolini, Franck-Emmanuel; Palandri, Francesca; Pappa, Vassiliki; Reiter, Andreas Johannes; Sacha, Tomasz; Schlager, Stefanie; Schmidt, Stefan; Terpos, Evangelos; Unger, Martin; Wölfler, Albert; Cirici, Blanca Xicoy; Klade, Christoph